Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.
Holze, F., Duthaler, U., Vizeli, P., Müller, F., Borgwardt, S., & Liechti, M. E. | British journal of clinical pharmacology | 29 Apr 2019
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use
Luethi, D., Hoener, M. C., Krähenbühl, S., Liechti, M. E., & Duthaler, U. | Biochemical pharmacology | 11 April 2019
Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
Dipasquale, O., Selvaggi, P., Veronese, M., Gabay, A. S., Turkheimer, F., Mehta, M. A. | NeuroImage | 4 April 2019
Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action
Coffeen, U., & Pellicer, F. | Journal of pain research | 22 March 2019
Metabolite Profiling of Antiaddictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae)
Krengel, F., Chevalier, Q., Dickinson, J., Santoyo, J. H., & Reyes-Chilpa, R. | Chemistry & biodiversity | 7 January 2019
Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom
Torrens-Spence, M. P., Liu, C. T., Pluskal, T., Chung, Y. K., & Weng, J. K. | ACS chemical biology | 28 November 2018